Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Pancreatic Cancer|Metastatic Colorectal Cancer
Interventions: DRUG: lurbinectedin (PM01183)|DRUG: capecitabine
Sponsor: PharmaMar